NoneDarius Tahir | (TNS) KFF Health News President-elect Donald Trump’s choice to run the sprawling government agency that administers Medicare, Medicaid, and the Affordable Care Act marketplace — celebrity doctor Mehmet Oz — recently held broad investments in health care, tech, and food companies that would pose significant conflicts of interest. Oz’s holdings, some shared with family, included a stake in UnitedHealth Group worth as much as $600,000, as well as shares of pharmaceutical firms and tech companies with business in the health care sector, such as Amazon. Collectively, Oz’s investments total tens of millions of dollars, according to financial disclosures he filed during his failed 2022 run for a Pennsylvania U.S. Senate seat. Trump said Tuesday he would nominate Oz as administrator of the Centers for Medicare & Medicaid Services. The agency’s scope is huge: CMS oversees coverage for more than 160 million Americans, nearly half the population. Medicare alone accounts for approximately $1 trillion in annual spending, with over 67 million enrollees. UnitedHealth Group is one of the largest health care companies in the nation and arguably the most important business partner of CMS, through which it is the leading provider of commercial health plans available to Medicare beneficiaries. UnitedHealth also offers managed-care plans under Medicaid, the joint state-federal program for low-income people, and sells plans on government-run marketplaces set up via the Affordable Care Act. Oz also had smaller stakes in CVS Health, which now includes the insurer Aetna, and in the insurer Cigna. It’s not clear if Oz, a heart surgeon by training, still holds investments in health care companies, or if he would divest his shares or otherwise seek to mitigate conflicts of interest should he be confirmed by the Senate. Reached by phone on Wednesday, he said he was in a Zoom meeting and declined to comment. An assistant did not reply to an email message with detailed questions. “It’s obvious that over the years he’s cultivated an interest in the pharmaceutical industry and the insurance industry,” said Peter Lurie, president of the Center for Science in the Public Interest, a watchdog group. “That raises a question of whether he can be trusted to act on behalf of the American people.” (The publisher of KFF Health News, David Rousseau, is on the CSPI board .) Oz used his TikTok page on multiple occasions in November to praise Trump and Robert F. Kennedy Jr., including their efforts to take on the “illness-industrial complex,” and he slammed “so-called experts like the big medical societies” for dishing out what he called bad nutritional advice. Oz’s positions on health policy have been chameleonic; in 2010, he cut an ad urging Californians to sign up for insurance under President Barack Obama’s Affordable Care Act, telling viewers they had a “historic opportunity.” Oz’s 2022 financial disclosures show that the television star invested a substantial part of his wealth in health care and food firms. Were he confirmed to run CMS, his job would involve interacting with giants of the industry that have contributed to his wealth. Given the breadth of his investments, it would be difficult for Oz to recuse himself from matters affecting his assets, if he still holds them. “He could spend his time in a rocking chair” if that happened, Lurie said. In the past, nominees for government positions with similar potential conflicts of interest have chosen to sell the assets or otherwise divest themselves. For instance, Treasury Secretary Janet Yellen and Attorney General Merrick Garland agreed to divest their holdings in relevant, publicly traded companies when they joined the Biden administration. Trump, however, declined in his first term to relinquish control of his own companies and other assets while in office, and he isn’t expected to do so in his second term. He has not publicly indicated concern about his subordinates’ financial holdings. CMS’ main job is to administer Medicare. About half of new enrollees now choose Medicare Advantage, in which commercial insurers provide their health coverage, instead of the traditional, government-run program, according to an analysis from KFF, a health information nonprofit that includes KFF Health News. Proponents of Medicare Advantage say the private plans offer more compelling services than the government and better manage the costs of care. Critics note that Medicare Advantage plans have a long history of costing taxpayers more than the traditional program. UnitedHealth, CVS, and Cigna are all substantial players in the Medicare Advantage market. It’s not always a good relationship with the government. The Department of Justice filed a 2017 complaint against UnitedHealth alleging the company used false information to inflate charges to the government. The case is ongoing. Oz is an enthusiastic proponent of Medicare Advantage. In 2020, he proposed offering Medicare Advantage to all; during his Senate run, he offered a more general pledge to expand those plans. After Trump announced Oz’s nomination for CMS, Jeffrey Singer, a senior fellow at the libertarian-leaning Cato Institute, said he was “uncertain about Dr. Oz’s familiarity with health care financing and economics.” Singer said Oz’s Medicare Advantage proposal could require large new taxes — perhaps a 20% payroll tax — to implement. Oz has gotten a mixed reception from elsewhere in Washington. Pennsylvania Sen. John Fetterman, the Democrat who defeated Oz in 2022, signaled he’d potentially support his appointment to CMS. “If Dr. Oz is about protecting and preserving Medicare and Medicaid, I’m voting for the dude,” he said on the social platform X. Oz’s investments in companies doing business with the federal government don’t end with big insurers. He and his family also hold hospital stocks, according to his 2022 disclosure, as well as a stake in Amazon worth as much as nearly $2.4 million. (Candidates for federal office are required to disclose a broad range of values for their holdings, not a specific figure.) Amazon operates an internet pharmacy, and the company announced in June that its subscription service is available to Medicare enrollees. It also owns a primary care service , One Medical, that accepts Medicare and “select” Medicare Advantage plans. Oz was also directly invested in several large pharmaceutical companies and, through investments in venture capital funds, indirectly invested in other biotech and vaccine firms. Big Pharma has been a frequent target of criticism and sometimes conspiracy theories from Trump and his allies. Kennedy, whom Trump has said he’ll nominate to be Health and Human Services secretary, is a longtime anti-vaccine activist. During the Biden administration, Congress gave Medicare authority to negotiate with drug companies over their prices. CMS initially selected 10 drugs. Those drugs collectively accounted for $50.5 billion in spending between June 1, 2022, and May 31, 2023, under Medicare’s Part D prescription drug benefit. At least four of those 10 medications are manufactured by companies in which Oz held stock, worth as much as about $50,000. Related Articles National Politics | Special counsel moves to dismiss election interference and classified documents cases against Trump National Politics | Donald Trump Jr. emerges as a political force of his own as he helps his father launch a second term National Politics | The rising price of paying the national debt is a risk for Trump’s promises on growth and inflation National Politics | What to know about Brooke Rollins, Trump’s pick for agriculture secretary National Politics | After Trump’s Project 2025 denials, he is tapping its authors and influencers for key roles Oz may gain or lose financially from other Trump administration proposals. For example, as of 2022, Oz held investments worth as much as $6 million in fertility treatment providers. To counter fears that politicians who oppose abortion would ban in vitro fertilization, Trump floated during his campaign making in vitro fertilization treatment free. It’s unclear whether the government would pay for the services. In his TikTok videos from earlier in November, Oz echoed attacks on the food industry by Kennedy and other figures in his “Make America Healthy Again” movement. They blame processed foods and underregulation of the industry for the poor health of many Americans, concerns shared by many Democrats and more mainstream experts. But in 2022, Oz owned stakes worth as much as $80,000 in Domino’s Pizza, Pepsi, and US Foods, as well as more substantial investments in other parts of the food chain, including cattle; Oz reported investments worth as much as $5.5 million in a farm and livestock, as well as a stake in a dairy-free milk startup. He was also indirectly invested in the restaurant chain Epic Burger. One of his largest investments was in the Pennsylvania-based convenience store chain Wawa, which sells fast food and all manner of ultra-processed snacks. Oz and his wife reported a stake in the company, beloved by many Pennsylvanians, worth as much as $30 million. ©2024 KFF Health News. Distributed by Tribune Content Agency, LLC.
Travel: Colorado’s winter huts blend adventure, luxury, and scenic beautyGOP senator claims woman in Pete Hegseth sex assault allegation ‘was the aggressor’
Israel launches new strikes on Lebanon as leaders draw closer to ceasefire with Hezbollah“Barbenheimer” was a phenomenon impossible to manufacture. But, more than a year later, that hasn’t stopped people from trying to make “Glicked” — or even “Babyratu” — happen. The counterprogramming of “Barbie” and “Oppenheimer” in July 2023 hit a nerve culturally and had the receipts to back it up. Unlike so many things that begin as memes, it transcended its online beginnings. Instead of an either-or, the two movies ultimately complemented and boosted one another at the box office. And ever since, moviegoers, marketers and meme makers have been trying to recreate that moment, searching the movie release schedule for odd mashups and sending candidates off into the social media void. Most attempts have fizzled (sorry, “Saw Patrol” ). This weekend is perhaps the closest approximation yet as the Broadway musical adaptation “Wicked” opens Friday against the chest-thumping sword-and-sandals epic “Gladiator II.” Two big studio releases (Universal and Paramount), with one-name titles, opposite tones and aesthetics and big blockbuster energy — it was already halfway there before the name game began: “Wickiator,” “Wadiator,” “Gladwick” and even the eyebrow raising “Gladicked” have all been suggested. “'Glicked' rolls off the tongue a little bit more,” actor Fred Hechinger said at the New York screening of “Gladiator II” this week. “I think we should all band around ‘Glicked.’ It gets too confusing if you have four or five different names for it.” As with “Barbenheimer," as reductive as it might seem, “Glicked” also has the male/female divide that make the fan art extra silly. One is pink and bright and awash in sparkles, tulle, Broadway bangers and brand tie-ins; The other is all sweat and sand, blood and bulging muscles. Both films topped Fandango’s most anticipated holiday movie survey, where 65% of respondents said that they were interested in the “Glicked” double feature. Theaters big and small are also pulling out the stops with movie-themed tie-ins. B&B Theaters will have Roman guards tearing tickets at some locations and Maximus popcorn tubs. Marcus Theaters is doing Oz photo ops and friendship bracelet-making. Alamo Drafthouse is leaning into the singalong aspect (beware, though, not all theaters are embracing this) and the punny drinks like “Defying Gravi-Tea.” “Rather than it being in competition, I think they’re in conversation,” “Gladiator II” star Paul Mescal said. “This industry needs a shot in the arm. Those films gave it last year. We hope to do it this year.” And the hope is that audiences will flock to theaters to be part of this moment as well. It's a sorely needed influx of could-be blockbusters into a marketplace that's still at an 11% deficit from last year and down 27.2% from 2019, according to data from Comscore. “Competition is good for the marketplace. It’s good for consumers,” said Michael O'Leary, the president and CEO of the National Association of Theatre Owners. “Having two great movies coming out at the same time is simply a multiplier effect.” “Glicked” is currently tracking for a combined North American debut in the $165 million range, with “Wicked” forecast to earn around $100 million (up from the $80 million estimates a few weeks ago) and “Gladiator II” pegged for the $65 million range. “Barbenheimer” shattered its projections last July. Going into that weekend, “Barbie” had been pegged for $90 million and “Oppenheimer” around $40 million. Ultimately, they brought in a combined $244 million in that first outing, and nearly $2.4 billion by the end of their runs. It’s possible “Glicked” will exceed expectations, too. And it has the advantage of another behemoth coming close behind: “Moana 2,” which opens just five days later on the Wednesday before the Thanksgiving holiday. “Glickedana” triple feature anyone? “These are 10 important days,” O'Leary said. “It’s going to show the moviegoing audience that there’s a lot of compelling stuff out there for them to see.” There are infinite caveats to the imperfect comparison to “Barbenheimer,” as well. “Wicked” is a “Part One.” Musicals carry their own baggage with moviegoers, even those based on wildly successful productions (ahem, “Cats”). “Gladiator II” got a head start and opened internationally last weekend. In fact, in the U.K. it played alongside “Paddington in Peru,” where that double was pegged “Gladdington.” “Gladiator” reviews, while positive, are a little more divided than the others. And neither directors Ridley Scott nor Jon M. Chu has the built-in box office cache that Christopher Nolan’s name alone carries at the moment. The new films also cost more than “Barbie” ($145 million) and “Oppenheimer” ($100 million). According to reports, “Gladiator II” had a $250 million price tag; “Wicked” reportedly cost $150 million to produce (and that does not include the cost of the second film, due next year). The narrative, though, has shifted away from “who will win the weekend.” Earlier this year, Chu told The Associated Press that he loves that this is a moment where “we can root for all movies all the time.” Close behind are a bevy of Christmas releases with double feature potential, but those feel a little more niche. There’s the remake of “Nosferatu,” the Nicole Kidman kink pic “Babygirl” and the Bob Dylan biopic “A Complete Unknown.” The internet can’t even seem to decide on its angle for that batch of contenders, and none exactly screams blockbuster. Sometimes the joy is just in the game, however. Some are sticking with the one-name mashup (“Babyratu”); others are suggesting that the fact that two of the movies feature real-life exes (Timothée Chalamet and Lily-Rose Depp) is enough reason for a double feature. And getting people talking is half the battle. When in doubt, or lacking a catchy name, there’s always the default: “This is my Barbenheimer.” Associated Press journalist John Carucci and Film Writer Jake Coyle contributed reporting.The suspect in the high-profile killing of a health insurance CEO that has gripped the United States graduated from an Ivy League university, reportedly hails from a wealthy family, and wrote social media posts brimming with cerebral musings. Luigi Mangione, 26, was thrust into the spotlight Monday after police revealed he is their person of interest in the brutal murder of United Healthcare CEO Brian Thompson, a father of two, last week in broad daylight in Manhattan in a case that laid bare deep frustration and anger with America's privatized medical system. News of his capture in Pennsylvania -- following a tip from a McDonald's worker --triggered an explosion of online activity, with Mangione quickly amassing new followers on social media as citizen sleuths and US media tried to understand who he is. While some lauded him as a hero and lamented his arrest, others analyzed his intellectual takes in search of ideological clues. A photo on one of his social media accounts includes an X-ray of an apparently injured spine. No explicit political affiliation has emerged. Meanwhile, memes and jokes proliferated, many riffing on his first name and comparing him to the "Mario Bros." character Luigi, sometimes depicted in AI-altered images wielding a gun or holding a Big Mac. "Godspeed. Please know that we all hear you," wrote one user on Facebook. "I want to donate to your defense fund," added another. According to Mangione's LinkedIn profile, he is employed as a data engineer at TrueCar, a California-based online auto marketplace. A company spokesperson told AFP Mangione "has not been an employee of our company since 2023." Although he had been living in Hawaii ahead of the killing, he originally hails from Towson, Maryland, near Baltimore. He comes from a prominent and wealthy Italian-American family, according to the Baltimore Banner. The family owns local businesses, including the Hayfields Country Club, its website says. A standout student, Mangione graduated at the top of his high school class in 2016. In an interview with his local paper at the time, he praised his teachers for fostering a passion for learning beyond grades and encouraging intellectual curiosity. A former student who knew Mangione at the Gilman School told AFP the suspect struck him as "a normal guy, nice kid." "There was nothing about him that was off, at least from my perception," this person said, asking that their name not be used. "Seemed to just be smiling, and kind of seemed like he was a smart kid. Ended up being valedictorian, which confirmed that," the former student said. Mangione went on to attend the prestigious University of Pennsylvania, where he completed both a bachelor's and master's degree in computer science by 2020, according to a university spokesperson. While at Penn, Mangione co-led a group of 60 undergraduates who collaborated on video game projects, as noted in a now-deleted university webpage, archived on the Wayback Machine. On Instagram, where his following has skyrocketed from hundreds to tens of thousands, Mangione shared snapshots of his travels in Mexico, Puerto Rico and Hawaii. He also posted shirtless photos flaunting a six-pack and appeared in celebratory posts with fellow members of the Phi Kappa Psi fraternity. However, it is on X (formerly Twitter) that users have scoured Mangione's posts for potential motives. His header photo -- an X-ray of a spine with bolts -- remains cryptic, with no public explanation. Finding a coherent political ideology has also proved elusive, though he had written a review of Ted Kaczynski's manifesto on the online site goodreads, calling it "prescient." Kaczynski, known as the Unabomber, carried out a string of bombings in the United States from 1978 to 1995, a campaign he said was aimed at halting the advance of modern society and technology. Mangione called Kaczynski "rightfully imprisoned," while also saying "'violence never solved anything' is a statement uttered by cowards and predators." According to CNN, handwritten documents recovered when Mangione was arrested included the phrase "these parasites had it coming." Mangione has also linked approvingly to posts criticizing secularism as a harmful consequence of Christianity's decline. In April, he wrote, "Horror vacui (nature abhors a vacuum)." The following month, he posted an essay he wrote in high school titled "How Christianity Prospered by Appealing to the Lower Classes of Ancient Rome." In another post from April, he speculated that Japan's low birthrate stems from societal disconnection, adding that "fleshlights" and other vaginal-replica sex toys should be banned. ia/nro/dw
Alex Ovechkin is expected to miss 4 to 6 weeks with a broken left leg